Enzo Biochem's Clinical Labs Division Signs Exclusive Marketing Agreement with Ikonisys Inc. for Proprietary Molecular-Based Cervical Cancer Test
NEW YORK--(BUSINESS WIRE)--Enzo Biochem, Inc. (NYSE:ENZ) announced today that its Enzo Clinical Lab division has entered into an exclusive marketing partnership covering the States of New York and New Jersey with privately-owned Ikonisys, Inc., of New Haven, CT, relating to Ikonisys’ proprietary oncoFISH® cervical test, a laboratory developed test for cervical cancer prevention.